The Atlanta pilot will focus on heart failure. Key stakeholders include Novartis AG, Takedo Pharmaceuticals, Kaiser Permanente, Qualcomm and international health officials, according to the report.
WEF plans to take a patient outcomes focus in its models, according to the report. “We believe that this is a model that should be adopted globally … We plan on sticking with this for several years,” said Rick Valencia, president of Qualcomm Life, according to Reuters.
The next pilots will be launched in the Netherlands, Singapore and China, according to the report. Read the full story here.
More articles on accountable care:
PCMHs in Michigan successfully reduce ED, hospital use and costs
Study: Turnover may be why ACOs have weak influence on cost, outcomes
Number of CPSI Rural ACO charter members exceeds 50: 3 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
